GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Cyclically Adjusted PS Ratio

Hisamitsu Pharmaceutical Co (TSE:4530) Cyclically Adjusted PS Ratio : 2.10 (As of May. 17, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-05-17), Hisamitsu Pharmaceutical Co's current share price is 円3796.00. Hisamitsu Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Nov. 2023 was 円1,808.95. Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 2.10.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4530' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.87   Med: 2.74   Max: 5.67
Current: 2.11

During the past years, Hisamitsu Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 5.67. The lowest was 1.87. And the median was 2.74.

TSE:4530's Cyclically Adjusted PS Ratio is ranked better than
51% of 747 companies
in the Drug Manufacturers industry
Industry Median: 2.17 vs TSE:4530: 2.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hisamitsu Pharmaceutical Co's adjusted revenue per share data for the three months ended in Nov. 2023 was 円467.826. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円1,808.95 for the trailing ten years ended in Nov. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hisamitsu Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.71 3.80 2.10 2.15 -

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 2.01 2.75 2.55 -

Competitive Comparison of Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Hisamitsu Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3796.00/1808.95
=2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Nov. 2023 is calculated as:

For example, Hisamitsu Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Nov. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Nov. 2023 (Change)*Current CPI (Nov. 2023)
=467.826/106.9000*106.9000
=467.826

Current CPI (Nov. 2023) = 106.9000.

Hisamitsu Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201402 414.460 95.500 463.935
201405 440.730 98.100 480.265
201408 458.701 98.300 498.832
201411 442.265 97.900 482.923
201502 487.971 97.600 534.468
201505 463.189 98.700 501.671
201508 499.002 98.400 542.107
201511 470.582 98.100 512.795
201602 467.001 97.800 510.454
201605 450.523 98.200 490.437
201608 426.762 97.900 465.994
201611 415.821 98.600 450.824
201702 432.372 98.100 471.158
201705 431.029 98.600 467.312
201708 446.523 98.500 484.602
201711 430.936 99.100 464.854
201802 464.738 99.500 499.301
201805 400.203 99.300 430.833
201808 428.532 99.800 459.019
201811 396.542 100.000 423.903
201902 491.754 99.700 527.267
201905 353.457 100.000 377.846
201908 413.191 100.000 441.701
201911 436.176 100.500 463.952
202002 512.521 100.300 546.246
202005 304.680 100.100 325.378
202008 342.476 100.100 365.741
202011 341.102 99.500 366.470
202102 411.929 99.800 441.235
202105 339.551 99.400 365.171
202108 376.346 99.700 403.524
202111 344.569 100.100 367.976
202202 419.550 100.700 445.381
202205 330.922 101.800 347.501
202208 416.199 102.700 433.220
202211 404.595 103.900 416.277
202302 465.612 104.000 478.595
202305 412.593 105.100 419.659
202308 448.636 105.900 452.872
202311 467.826 106.900 467.826

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hisamitsu Pharmaceutical Co  (TSE:4530) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Hisamitsu Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines